Teiko
@TeikoBio
Followers
122
Following
501
Media
140
Statuses
369
We make high-dimensional cytometry simple for clinical trials.
Salt Lake City, Utah
Joined January 2021
We are thrilled to announce that @zumutor has selected Teiko to develop a custom 42-marker cytometry panel to support the development of their first-in-class innate immune checkpoint therapeutic candidate, ZM008. Through this collaboration, we will build and validate the custom
0
0
0
Tailored gating, peer-reviewed by our in-house team of experts for your clinical trial 🙂↔️ Learn more here: https://t.co/Nu0v0PIbM4
0
0
0
Cytometry datasets for clinical trials are massive, with thousands of comparisons across populations, markers, endpoints, and timepoints. As one translational scientist put it: “Many times, the data just sits for months or years as there is not enough bioinformatics support to
0
0
0
Ever sent blood samples to a CRO and wondered… “Where are they now?” Your dashboard now includes a specimen tracking feature that makes it easy to follow your blood samples in real time. 👀 Whether you’re sending: • PBMCs isolated at clinical sites, or • Whole blood
0
1
1
Our CSO, Li-Chun Cheng, will be presenting at ICCS 2025 (40th Annual Meeting & Course of The International Clinical Cytometry Society hosted by @ICCS_Education) in Philadelphia, PA. • Poster #111: Comparison of Whole Blood Preservation Methods for Cytometric Analysis • Dates:
0
1
0
New Cytometry Dataset: Immune Checkpoint Inhibitor Adverse Events We’re releasing a 43-marker mass cytometry dataset from 70 melanoma patient PBMC specimens from @huntsmancancer — the same data behind our recent @jitcancer co-publication. Key findings: • ↑ CD4⁺ naïve T
0
1
1
Does blood volume affect immune cell preservation with our TokuKits? No. From 0.5 mL to 3 mL blood inputs, TokuKit preserves immune cell populations within +/-2% of the standard 2 mL blood volume. Even at the lowest (0.5mL) and highest (3mL) volumes tested, 95% of cell
0
1
0
Until now, cytometry QC has often been a black-box pass/fail, based on a single metric. That’s risky. Our new Sample Overview dashboard changes that. Depending on the sample type and cytometer (spectral or mass), it applies specific criteria to determine pass/fail status, and
0
1
0
Accessing and reviewing all your gating plots in a clinical trial shouldn’t be difficult, especially when thousands of dollars are at stake. That’s why we built “Download All”: a simple way to bulk-download every gating plot for your cell populations and functional markers per
0
0
0
20% of live samples fail before they even reach analysis: lost to shipping delays, site variability, and logistics headaches. As a drug developer, the simple question “Did my sample arrive?” shouldn’t require phone calls, emails, and waiting. That’s why we’ve released real-time
0
1
0
We had a fantastic time at the Multiomics Mixer hosted by Latch Bio! A big thank you to Biomodal for pulling together such a thoughtful event. It was exciting to be in the room with companies with high energy, drive, and hustle like @biomodalhq , @LatchBio , @10xGenomics,
0
2
3
Working with a big-box CRO can feel like dating. It starts with high expectations: “You’ll get access to all the data!” YAY! Then comes: “...but there’s a $5K data pull fee.” Oh. Then: “You can analyze across multiple endpoints!” YAY! But: “It’s raw FCS files—you’ll need to
0
1
0
Translational scientists often ask: “Interesting. But are these immune changes real? Can I see the gating behind it?” Now you can! With ‘Hover Over Gating’, every datapoint in a boxplot is instantly linked to its original cytometry gating plot and sample metadata. See the
0
0
0
High CVs aren’t just annoying, they derail timelines and make your data harder to trust. At Teiko, consistent QC is front and center. In our CLIA-validation studies, we kept CVs low across platforms: • Spectral cytometry → Intra-run: 3.38%, Inter-run: 4.56% • Mass cytometry
0
1
1